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a b s t r a c t
Sexual disruption in wild ﬁsh has been linked to the contamination of river systems with steroid oestro-
gens, including the pharmaceutical 17-ethinylestradiol, originating from domestic wastewaters. As
analytical chemistry has advanced, more compounds derived from the human use of pharmaceuticals
have been identiﬁed in the environment and questions have arisen as to whether these additional
pharmaceuticals may also impact sexual disruption in ﬁsh. Indeed, pharmaceutical anti-androgens have
been shown to induce such effects under laboratory conditions. These are of particular interest since anti-
androgenic biological activityhasbeen identiﬁed in the aquatic environment and is potentially implicated
in sexual disruption alone and in combination with steroid oestrogens. Consequently, predictive mod-
elling was employed to determine the concentrations of two anti-androgenic human pharmaceuticals,
bicalutamide and cyproterone acetate, in UK sewage efﬂuents and river catchments and their com-
bined impacts on sexual disruption were then assessed in two ﬁsh models. Crucially, ﬁsh were also
exposed to the anti-androgens in combination with steroid oestrogens to determine whether they had
any additional impact on oestrogen induced feminisation. Modelling predicted that the anti-androgenic
pharmaceuticals were likely to be widespread in UK river catchments. However, their concentrations
were not sufﬁcient to induce signiﬁcant responses in plasma vitellogenin concentrations, secondary
sexual characteristics or gross indices in male fathead minnow or intersex in Japanese medaka alone
or in combination with steroid oestrogens. However, environmentally relevant mixtures of oestrone,
17-oestradiol and 17-ethinylestradiol did induce vitellogenin and intersex, supporting their role in
sexual disruption in wild ﬁsh populations. Unexpectedly, a male dominated sex ratio (100% in controls)
was induced in medaka and the potential cause and implications are brieﬂy discussed, highlighting the
potential of non-chemical modes of action on this endpoint.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Pharmaceuticals have emerged as contaminants of con-
cern in the aquatic environment, where they are present at
nanogram–microgram per litre concentrations globally (Heberer,
2002). They enter river systems primarily through sewage efﬂu-
ent, following patient excretion and incomplete removal during
sewage treatment. However, hospitals, manufacturers, landﬁlls
and improper disposal by patients can also be prominent sources
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(Bound and Voulvoulis, 2005; Larsson et al., 2007; Kümmerer,
2009). Some pharmaceuticals have the capacity to induce adverse
effects in non-target organisms through their speciﬁc interactions
with conserved drug targets (Gunnarsson et al., 2008; Rand-
Weaver et al., 2013). One of the most notorious examples is
17-ethinylestradiol (EE2), the active hormone in the contracep-
tive pill, which has been linked to feminisation of ﬁsh downstream
of sewage efﬂuent outfalls, alongside the other steroid oestro-
gens 17-oestradiol (E2) and oestrone (E1) (Desbrow et al., 1998;
Routledge et al., 1998; Jobling et al., 2006). Fish exposed to EE2 in
the lownanogramper litre range showdramaticdecreases in repro-
ductive success, prompting concerns over the potential effects of
this chemical on ﬁsh populations (Kidd et al., 2007).
http://dx.doi.org/10.1016/j.aquatox.2014.12.022
0166-445X/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
118 C. Green et al. / Aquatic Toxicology 160 (2015) 117–127
Several studies have demonstrated that sexual disruption,
including the induction of vitellogenin and intersex, occurs in ﬁsh
exposed to STW efﬂuents under laboratory conditions and in the
wild (Jobling et al., 1998; Bjerregaard et al., 2006; Jobling et al.,
2006; Harris et al., 2011; Lange et al., 2011; Tetreault et al., 2011;
Bahamonde et al., 2013). Whilst the steroid oestrogens are clearly
signiﬁcant contributors to intersex through disruption of normal
endocrine function, the relative role of other pharmaceuticals that
co-occur with these compounds is unclear. Nonetheless, pharma-
ceuticals that can interact with hormone receptors or affect levels
of circulating hormones are in widespread use and many are pre-
scribed in greater amounts than the oestrogens (Runnalls et al.,
2010). Of particular interest are anti-androgenic pharmaceuticals.
These compounds are designed to disrupt the androgen signalling
pathway through the competitive inhibition of androgen binding
to the androgen receptor (AR) by direct antagonism, or by reduc-
ing concentrations of circulating androgens (Kelce and Wilson,
1997; Hotchkiss et al., 2008). Anti-androgenic activity has also
been detected in STW efﬂuents, river water and sediment glob-
ally (Conroy et al., 2007; Johnson et al., 2007b; Urbatzka et al.,
2007; Weiss et al., 2009; Kumar et al., 2012; Kinani et al., 2010) and
there is some evidence of anti-androgenic pharmaceuticals poten-
tially occurring in low nanogram per litre concentrations (Besse
and Garric, 2009; Al-Odaini et al., 2012; AZ.com, 2013).
Anti-androgens can cause demasculinisation of male ﬁsh
under laboratory conditions, inducing similar phenotypes to those
observed in theaquatic environmentor throughexposure to steroid
oestrogens. These include intersex and vitellogenin induction,
altered gene expression and reduced secondary sexual character-
istics, sperm counts and fecundity (Bayley et al., 2002; Kiparissis
et al., 2003; Jensen et al., 2004; Filby et al., 2007; Hatef et al., 2012).
Furthermore, several studies have shown that the anti-androgenic
activity of some STW efﬂuents is equivalent to concentrations of
the anti-androgenic pharmaceutical, ﬂutamide, that are capable
of causing demasculinisation in ﬁsh during laboratory exposures
(Jensen et al., 2004; Panter et al., 2004; Johnson et al., 2007b).
Anti-androgenic impacts have been detected in wild stickleback
(Gasterosteus aculeatus)downstreamof a STWefﬂuent outfall in the
UK (Katsiadaki et al., 2012) and anti-androgenic compounds have
been identiﬁed in the bile of ﬁsh exposed to STWefﬂuent (Hill et al.,
2010; Rostkowski et al., 2011). However, the chemical contributors
to anti-androgenic activity in the environment are not well char-
acterised and pharmaceutical mixtures have not been investigated
from this perspective.
This study aimed to determinewhether the two of themost pre-
scribed anti-androgenic pharmaceuticals in the UK, bicalutamide
and cyproterone acetate, could contribute to feminization of ﬁsh at
environmentally relevant concentrations. Both drugs are AR antag-
onists, although unlike bicalutamide, cyproterone acetate can also
inhibit androgen secretion by inhibiting gonadotrophin release
through its progestagenic activity (Mahler et al., 1998). Both can
cause demasculinising effects in male patients during treatment
through either intended or adverse effects, such as gynecomastia
and reduced libido (Mahler et al., 1998; Bradford, 1999). In fact,
the use of cyproterone acetate to treat sexually deviant behaviour
in men has been shown to be equivalent to surgical castration
(Neumann and Kalmus, 1991). In ﬁsh, exposures to these com-
pounds caused similar effects to the steroid oestrogens, including
intersex and impacts on reproduction (Kiparissis et al., 2003; Panter
et al., 2012). However, although they are likely environmental con-
taminants due to their prescription levels and patient excretion,
there are few available data on their environmental concentra-
tions and corresponding effects in ﬁsh. In addition, there has been
no assessment of the possibility of combined effects with steroid
oestrogens, with which they are likely to co-occur in the aquatic
environment. This iswarranted since outcomes ofmodelling of ﬁsh
ﬁeldwork studies indicated that anti-androgenic chemicals may
play a signiﬁcant role in sexual disruption alone and in combi-
nation with steroid oestrogens (Jobling et al., 2009). There is also
evidence fromrodent studies that two sets of chemicalswithdiffer-
ent mechanisms of action can act additively on common endpoints
(Kortenkamp, 2008; Christiansen et al., 2009), although there may
in fact be some commonalities in the mode of action of oestrogens
and anti-androgens in ﬁsh at a molecular level (Filby et al., 2007).
To address these knowledge gaps, this study used predictive
modelling techniques to predict concentrations of bicalutamide
and cyproterone acetate in typical UK sewage efﬂuents. This was
later supplemented with modelling of concentrations in river
catchments in England and Wales to further investigate the wider
environmental relevance of the exposure concentrations. Such
techniques have already been used to predict concentrations of a
range of pharmaceuticals in STW efﬂuents and rivers (Schowanek
and Webb, 2002; Johnson et al., 2007a; Besse and Garric, 2009;
Johnson and Williams, 2004; Williams et al., 2009; Kugathas et al.,
2012) and comparisons of modelled and measured steroid oestro-
gens have been shown to compare well in two UK river catchments
(Williams et al., 2012). The modelled concentrations of bicalu-
tamideandcyproteroneacetate fromSTWefﬂuentswereemployed
in twoexperimentsusing twoappropriateﬁshmodels. Theseaimed
to determine whether the anti-androgenic pharmaceuticals could
induce effects associated with feminisation in ﬁsh, alone or in
combination with environmentally relevant mixtures of steroid
oestrogens.
2. Materials and methods
2.1. Prediction of sewage treatment works efﬂuent
concentrations of pharmaceutical anti-androgens
The NHS prescriptions cost analysis for England and Wales was
used to determine the annual consumption of bicalutamide and
cyproterone acetate in 2009 (based on Runnalls et al., 2010). The
daily per-capita consumption was then calculated based on the
mid-2009 population (estimated as 54,809,100). Excretion rates of
55% for bicalutamide (Goa and Spencer, 1998) and 80.75%, cypro-
terone acetate (Speck et al., 1976; Humpel et al., 1977; Frith and
Phillipou, 1985), were incorporated to determine the microgram
per day of each drug excreted per capita as the parent compound
in faeces and urine. Efﬂuent concentrations (microgram per litre)
were calculated for four UK STWs in the Severn Trent catchment
based on the linear emission model:
Cefﬂuent =
pc × pop
QSTW
× (1 − R)
where the per capita excreted (pc) was multiplied by the popu-
lation served by the STW (pop) and divided by the ﬂow (L/day)
(Q) through the STW (Table S2). Since removal is expected to be
low for bicalutamide (Brixham Environmental Laboratory, 1998;
AZ.com, 2013) andnodatawere available for cyproterone acetate, a
removalpercentage (R)wasnot incorporated. Thisprovidedaworst
case scenario where the total anti-androgenic pharmaceutical load
arriving at a STW was available to enter the aquatic environment.
These data are displayed in Tables S1 and S2.
2.2. Experimental test chemicals
Bicalutamide ≥98% (CAS No. 90357-06-5), cyproterone acetate
≥98% (CAS No. 427-51-0), oestrone (E1) ≥99% (CAS No. 53-
16-7), 17-oestradiol (E2) ≥99% (CAS No. 50-28-2) and 17-
ethinylestradiol (EE2) ≥98% (CAS No. 57-63-6) were purchased
fromSigma–Aldrich,Gillingham(UK). Concentrated stock solutions
were prepared with N,N-dimethylformamide (DMF) ≥99.8% (CAS
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No. 68-12-2) purchased from Fisher Scientiﬁc, UK for tank dosing
and Absolute Ethanol 100 AR (CAS No. AR 64-17-5) purchased from
Hayman Speciality Products, UK for Petri dish dosing in experiment
two.
2.3. Experiment one: vitellogenin induction and secondary sexual
characteristics
2.3.1. Experimental design, chemical concentrations and test
species
Experiment one was carried out using the experimental sys-
tem described by (Brian et al., 2005). Pre-spawning, male fathead
minnow of approximately seven months of age were exposed
to deﬁned mixtures of steroid oestrogens and anti-androgenic
pharmaceuticals for 14 days. Fathead minnow were an appropriate
experimental model for this experiment since males have a set of
well-deﬁned androgendependent secondary sexual characteristics
(Ankley et al., 2004; Ankley et al., 2010). They are also large enough
in size to allow for the collection of sufﬁcient blood for vitellogenin
analysis (Ankley and Johnson, 2004).
Six treatment groups were employed, including aquarium
water and solvent controls, a steroid oestrogen treatment (E1,
E2 and EE2), an anti-androgenic pharmaceutical treatment (bica-
lutamide and cyproterone acetate) and a combined mixture
treatment containing both anti-androgenic pharmaceuticals and
steroid oestrogens. Concentrations of the anti-androgenic pharma-
ceuticals were based on the maximum concentrations predicted
for untreated efﬂuent (115ng/L bicalutamide and 74ng/L cypro-
terone acetate) using the equation described in Section 2.1. Since
the steroid oestrogens occur together in the environment, ﬁsh
were exposed to an environmentally relevant mixture of 9.6ng/L
E1, 2.1ng/L E2 and 0.3ng/L EE2. These were within the range of
oestrogen concentrations observed in a survey of UK efﬂuents and
their proportions were based on the ratio of their highest detected
concentrations (Johnson et al., 2007b). These concentrations had
a combined E2 equivalent (EEQ) of 8.3ng/L, based on PNECs for
reproductive endpoints (as described in Young et al., 2004) and
were expected to induce an intermediate response in vitellogenin
induction based on their estimated EC50’s for this endpoint (Panter
et al., 1998; Brian et al., 2005). A positive control of 10ng/L EE2 was
also included. All treatments were run in duplicate with eight ﬁsh
per tank.
Chemical stocks were prepared at 50,000× the required expo-
sure concentration in 1 L DMF and were pumped by peristaltic
pump through medical grade silicone tubing (Watson Marlow, UK)
to mixing vessels at a rate of 0.01mL/min. This was mixed with
dechlorinated and ﬁltered tap water from a header tank ﬂowing at
30 L/h via medical grade silicone tubing (VWR, UK), to produce the
desired concentrations in the exposure aquaria without exceed-
ing the maximum recommended concentration of 20L/L of DMF
(Hutchinson et al., 2006). Each tank had its own mixing vessel,
although single stock bottles fed both replicates and the negative
control ran directly off the header tank. Physical and physico-
chemical conditions were maintained at 25±1 ◦C with dissolved
oxygen exceeding 70% of air saturation and a photoperiod of 16:8h
light:dark with a 20min simulated dusk/dawn period of low light.
The ﬁsh were fed twice daily with ﬂaked food (Tetramin Flake,
ZM Fish Food, UK) and once daily with frozen adult brine shrimp
(Tropical Marine Centre, Gamma irradiated).
2.3.2. Fish sampling and vitellogenin analysis
After 14 days of chemical exposure, ﬁsh were sacriﬁced by a
lethal dose of MS222 (500mg/L), buffered to pH 7.4, in accordance
withUKHomeOfﬁce Regulations. Bloodwas collected by caudal ﬁn
amputation with heparinised microhematocrit tubes and samples
were centrifuged at 7000× g for 5min at 4 ◦C to collect plasma,
which were stored at −80 ◦C. Fork length and wet weight were
recorded and the livers and gonads were excised and weighed for
hepatosomatic index (HSI) and gonadosomatic index (GSI). Sec-
ondary sexual characteristics, including the fatpad weight and the
tubercle number, were also recorded. Tubercle prominence was
then graded (scored 0–5) based on their level of development
(based on Smith, 1978). Plasma samples from individual ﬁsh were
then analysed by enzyme linked immunosorbent assay (ELISA) spe-
ciﬁc to fathead minnow (Biosense Laboratories AS, Norway).
2.4. Experiment two: intersex induction in Japanese medaka
(Oryzias latipes)
2.4.1. Experimental design, chemical concentrations and test
species
Japanese medaka were exposed from an embryo to early adult
stage over 98 days. This species can reach sexual maturity within
100 days, are sexually dimorphic and have well documented
process of gonad development (Ankley and Johnson, 2004). As
in experiment one, ﬁsh were treated with the anti-androgenic
pharmaceuticals, the steroid oestrogens and a combination of the
two sets of compounds. However, this treatment regimewas tested
at two different concentrations termed “high” and “low.” Con-
centrations of anti-androgenic pharmaceuticals were based on
those predicted from the UK sewage efﬂuents based on the equa-
tion described in Section 2.1. In addition, the concentrations of
steroid oestrogens predicted to occur at these STWs were also
employed, based on the same ﬂow regimens and populations
served (from Green et al., 2013). For the high concentrations, the
treatment concentrations originated from UK1: 115ng/L bical-
tuamide, 74ng/L cyproterone acetate, 29ng/L E1, 4ng/L E2 and
0.4ng/L EE2 (17.7ng/L EEQ). The low concentrations were based
on the lowest efﬂuent concentrations predicted for UK3: 53ng/L
bicalutamide, 34ng/L cyproterone acetate, 13ng/L E1, 2ng/L E2
and 0.2ng/L EE2 (equivalent to 8.3ng/L EEQ). The steroid oestro-
gen concentrations were both expected to induce an intermediate
incidence of intersex based on a concentration response of E2 in
medaka for the induction of intersex (Metcalfe et al., 2001). A pos-
itive control was dosed at 50ng/L E2, a concentration expected to
completely reverse the sex of males (Kinoshita et al., 2009), and an
aquarium water and solvent control were also employed to give a
total of nine treatments.
Each treatment was replicated in duplicate with 25 ﬁsh per
tank (50 per treatment). Embryos were collected and exposure
was initiated at less than six hours post fertilisation. The embryos
were maintained under static renewal in covered glass Petri dishes
with 15mL of Modiﬁed FETAX (Frog Embryo Teratogenesis Assay-
Xenopus) Solution (MFS) (from Woods and Kumar, 2011) in an
incubator at 25±1 ◦C with 16:8h light:dark ratio. Over the ﬁrst
three days, unfertilised or dead embryos were replaced with new
fertilised embryos. Each Petri dish was spiked with 10L of a con-
centrated stock solution in absolute ethanol, which was allowed to
evaporate before 15mLofMFSwas added. Nonetheless, the solvent
control was still spiked with ethanol only. Embryos were trans-
ferred, by pipette, to new Petri dishes with new stocks daily to
provide 24h renewal of the exposure mixtures. As the embryos
hatched, larvae were transferred to 30 L exposure aquaria run with
the same ﬂow regimens as experiment one andweremaintained in
meshbaskets for up to14days before being released into the aquar-
ium itself. Temperaturewasmaintained at 26±1 ◦C throughout the
majority of the study, although greater ﬂuctuations were observed
in some tanks on occasion. A photoperiod of 16:8h light:dark with
a 20min simulated dusk/dawn period of low lightwas applied. Fish
were fed twice daily to excess with pellet food. This was supple-
mented with larval artemia and, eventually, frozen brine shrimp.
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Dissolved oxygen and various water parameters were monitored
throughout the experiment.
2.4.2. Fish sampling and histological analysis
After 98 days exposure, medaka were sacriﬁced by a lethal dose
of neutral bufferedMS222 (500mg/L). However, ﬁsh in the positive
control treatment were sampled earlier at 90 days due to mortal-
ity during the exposure. The heads and tails were removed and the
body was ﬁxed in bouins and stored in 70% IMS. The body cavity
was then opened from the side to reveal the gonad before being
ﬁxed in wax and serial sectioned longitudinally, with 5m sam-
ples taken every 150m across the gonad. For smaller ﬁsh, the
entire body was serial sectioned and for females with large ovaries,
the gonad was excised and split longitudinally into sections before
being set in wax and serial sectioned in the same fashion as the
males. Intersex incidence was quantiﬁed through light microscopy
by the presence or absence of oocytes and ovarian cavities and
severity was scored for each gonad section based on an intersex
index score of 0–6, shown in Table S3 (from Jobling et al., 2006), for
the number of oocytes. All slides were blinded prior to microscopic
analysis.
2.5. Chemical analysis
Concentrations of the exposure chemicals were analysed by
liquid chromatography tandem mass-spectrometry (LC–MS/MS).
The method for analysing steroid oestrogens was taken from the
Standing Committee of Analysts book on the detection of steroid
oestrogens in water samples by mass spectrometry (Environment
Agency, 2008). Methods were developed for detecting cyproterone
acetate and bicalutamide and are detailed in the Supporting Infor-
mation. Brieﬂy, in experiment one, 500mL samples from treatment
tanks were collected on days 1 and 14. In experiment two, 100mL
was collected on days 20, 34, 62 and 90 for solid phase extrac-
tion using C18 cartridges (Sep-Pak C18, Waters, UK). Extracts
underwent HPLC (Aglient 1100 series) with a C18 column (Aglient
ZORBAX Eclipse XDB-C18, 150mm×4.6×5m. Part No. 993967-
902). Detection and quantiﬁcationwas carried out using anApplied
Biosystems API5000 triple quadrupole mass spectrometer using
negative ion electrospray inmultiple reactionmonitoringmode for
bicalutamide and the steroid oestrogens. Positive ion electrospray
was employed for cyproterone acetate. The concentrations were
then calculated from calibration curves using deuterium labelled
internal standard quantitation in Analyst 1.5.1 software (Thermo-
Electron Corporation) with d7-propanolol and d10-carbamazapine
for bicalutamide and cyproterone acetate, respectively. Limits
of detection (LOD) were determined as 5ng/L bicalutamide and
10ng/L cyproterone acetate. The LOD for the steroid oestrogens in
experiment one was determined as 0.1ng/L, compared with 1ng/L
in experiment two. Analysis of samples yielded variable recovery,
which in the case of cyproterone acetate could not be recovery
corrected using d10-carbamazapine. Consequently, the concentra-
tion of cyproterone acetate could not be accurately quantiﬁed in
samples and had to be predicted from the bicalutamide data using
dose ratio information. Concentrations of EE2 in samples could not
be reported directly due their low concentration in samples and
were estimated from analysed E2 concentrations using dose ratio
information.
2.6. Statistical analysis
In experimentone, parametric dataunderwentonewayanalysis
of variance (ANOVA) followed by post hoc all pairwise multi-
ple comparisonprocedures (Holm–Sidakmethod).Non-parametric
data was assessed by Kruskal–Wallis one way ANOVA on ranks
followed by post hoc all pairwise multiple comparison procedures
(Dunn’s method). Vitellogenin data were log transformed prior to
assessment and statistical signiﬁcance was accepted at P≤0.05
for all tested endpoints. Treatment groups were all compared
with the solvent control. In experiment two, binary responses
(intersex incidence) were analysed using generalized linear mod-
elling approaches, assuming that the numbers of intersex ﬁsh
were binomial-distributed. Mean effects were estimated by Maxi-
mum likelihood, and treatment-related differences to the controls
were analysed by Williams contrast test (Hothorn, 2004). Ordinal
responses (intersex severity) were assumed to follow a common
slopes model with a cumulative logit link function, and correla-
tions from repeated measurements were estimated according to
the principles of generalized estimating equations (Agresti, 1984).
Odds ratio estimates were used to express relative differences
between treatment means. For the log odds scale, the cumula-
tive logit model is sometimes referred to as the proportional odds
model. Analysis of vitellogenin, secondary sexual characteristics
and gross indices was performed in SigmaStat 3.5 (Systat Software,
Chicago IL), whilst intersex analysis was performed in SAS 9.3 (SAS
Institute, Cary NC).
2.7. Environmental relevance
In order to put the exposure concentrations into context and
to produce a more extensive picture of anti-androgenic pharma-
ceuticals in UK rivers, predictive modelling techniques were used
to estimate their concentrations in river catchments in the England
andWales. Fourteenmajor river catchmentsaccounting forapprox-
imately 54% of land area and 69% of the population served by STWs
were assessed (Figure S3 A&B). The modelling exercise used the
Low Flows 2000 (LF2000) WQX (Water Quality eXtension) hydro-
logical modelling platform, which provided a map of the UK’s
interconnected river reaches with their variable ﬂows and artiﬁ-
cial inﬂuences incorporated (Williams et al., 2009). In this process,
STW’s were considered to be the only chemical input based on the
per capita excretion and once again a removal percentage was not
incorporated. There are no data available on the in-stream degra-
dation of the pharmaceutical anti-androgens, and so the model
produced a worst case scenario for their environmental concentra-
tions, only taking into account the effects of dilution of the efﬂuent
in downstream river stretches.
3. Results
3.1. Predicted environmental concentrations of anti-androgenic
pharmaceuticals
NHS prescriptions of bicalutamide and cyproterone acetate
in 2009 were determined as 636kg and 278kg, respectively,
which produced per capita excretion rates of 17 and 11g/day.
When these data were input to the linear emission model (Sec-
tion 2.1), concentrations of 53–115ng/L for bicalutamide and
34–74ng/L for cyproterone acetate were predicted to occur in
untreated efﬂuent at the four UK STWs. The highest and lowest
predicted concentrations from this analysis were used as exposure
concentrations for experiments one and two. Subsequent hydro-
logical modelling with LF2000-WQX predicted that the presence
of anti-androgenic pharmaceuticals was widespread across river
catchments in England and Wales, downstream of STW discharges.
The concentrations on a majority of river stretches were below
10ng/L, although they were much higher on some stretches from
both urban and rural areas. Indeed, median concentrations of 9
(0.0002–157)ng/L bicalutamide and 5 (0.0001–86)ng/L of cypro-
terone acetate were predicted (Figure S3 A&B).
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Table 1
Chemical analysis of exposure tanks fromexperiments one and twoversus the nominal. In experiment one, samples analysed at the start and endof the exposure are indicated. In experiment two, themeanmeasured concentrations
(± standard error) are displayed from analysis of up to four samples from throughout the study. Cyproterone acetate was predicted based on bicalutamide and, in experiment two, EE2 was predicted based on E2.
Experiment one Replicate Bicalutamide (ng/L) Cyproteroneacetate (ng/L) E1 (ng/L) E2 (ng/L) EE2 (ng/L) EEQ (ng/L)
Treatment
Nominal Measured Nominal Predicted Nominal Measured Nominal Measured Nominal Measured Nominal Predicted
Anti-androgens A 115 94 (±27) 74.0 60 (±17) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
B 115 121 (±64) 74.0 78 (±41) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
Steroid oestrogens A 0 <LOD 0 <LOD 9.6 10.3 (±1.1) 2.1 2.0 (±1.0) 0.3 0.3 (±0.1) 8.3 8.2 (±2.4)
B 0 <LOD 0 <LOD 9.6 8.7 (±1.9) 2.1 1.7 (±0.6) 0.3 0.2 (±0.1) 8.3 6.9 (±1.9)
Mixture A 115 94 (±29) 74.0 60 (±19) 9.6 10.6 (±3.1) 2.1 2.0 (±0.2) 0.3 0.3 (±0.1) 8.3 8.4 (±1.8)
B 115 90 (±17) 74.0 58 (±11) 9.6 7.0 (±4.4) 2.1 1.3 (±0.9) 0.3 0.2 (±0.1) 8.3 5.3 (±3.3)
Positive Control A 0 <LOD 0 <LOD 0 <LOD 0 <LOD 10.0 9.7 (±2.8) 100.0 97 (±28)
B 0 <LOD 0 <LOD 0 <LOD 0 <LOD 10.0 9.0 (±2.7) 100.0 90 (±27)
Experiment two Replicate Bicalutamide (ng/L) Cyproteroneacetate (ng/L) E1 (ng/L) E2 (ng/L) EE2 (ng/L) EEQ (ng/L)
Treatment
Nominal Measured Nominal Predicted Nominal Measured Nominal Measured Nominal Predicted Nominal Predicted
Low anti-androgens A 53 99 (±18) 32 57 (±8) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
B 53 71 (±7) 32 43 (±4) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
Low oestrogens A 0 <LOD 0 <LOD 13 24 (±2) 2 3.2 (±0.4) 0.2 0.3 (±0.04) 8 14 (±1)
B 0 <LOD 0 <LOD 13 27 (±4) 2 3.4 (±0.4) 0.2 0.3 (±0.04) 8 16 (±2)
Low mixture A 53 107 (±6) 32 64 (±4) 13 33 (±6) 2 3.9 (±0.8) 0.2 0.4 (±0.08) 8 20 (±4)
B 53 85 (±16) 32 52 (±10) 13 34 (±5) 2 3.7 (±0.8) 0.2 0.4 (±0.08) 8 20 (±4)
High anti-androgens A 115 133 (±14) 74 85 (±9) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
B 115 152 (±11) 74 98 (±7) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
High oestrogens A 0 <LOD 0 <LOD 29 63 (±2) 4 8.3 (±0.7) 0.4 0.8 (±0.07) 18 37 (±2)
B 0 <LOD 0 <LOD 29 66 (±7) 4 6.8 (±0.4) 0.4 0.7 (±0.04) 18 36 (±3)
High mixture A 115 99 (±30) 74 64 (±19) 29 64 (±10) 4 8.7 (±1.9) 0.4 0.9 (±0.19) 18 39 (±2)
B 115 134 (±5) 74 86 (±3) 0 61 (±7) 4 9.5 (±2.2) 0.4 1.0 (±0.22) 18 39 (±3)
Positive control A 0 <LOD 0 <LOD 0 <LOD 50 76 (±4) 0 <LOD 50 77 (±5)
B 0 <LOD 0 <LOD 0 <LOD 50 80 (±10) 0 <LOD 50 81 (±11)
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3.2. Chemical analysis
The results of chemical analysis are displayed below in Table 1.
Concentrations of bicalutamide were successfully determined.
However, whilst cyproterone acetate was successfully detected
in the anti-androgen and mixture treatment tanks it could not
be accurately quantiﬁed due to the unreliable quantiﬁcation of
the internal standard. Concentrations of cyproterone acetate were
instead predicted based on its expected ratio to bicalutamide, with
which it had been combined in the stock solutions. In experiment
one, all compounds were close to nominal with good agreement
between replicates as well as between the single activity and com-
bined mixture treatments. In experiment two, the concentrations
tended to be around 200% of nominal due to issues in maintain-
ing header tank pressure, which caused sporadic reductions the
ﬂow and therefore the dilution of the chemicals. Nonetheless, envi-
ronmentally relevant concentrations were maintained throughout
the experiment based on predictive modelling for anti-androgenic
pharmaceuticals and reported oestrogen concentrations from UK
rivers and efﬂuents (Johnson et al., 2007b; Williams et al., 2009).
EE2 was below the 1ng/L LOD of the method and was instead pre-
dicted based on themeasured concentration of E2. Good agreement
was achieved between replicate tanks and between single activity
and mixture treatment tanks. Concentrations of steroid oestrogens
in the high and low mixtures differed, whilst the anti-androgens
were more similar.
3.3. Experiment one: vitellogenin induction, secondary sexual
characteristics and gross indices
Vitellogenin levels in the blood plasma of juvenile male fathead
minnows varied signiﬁcantly between treatments (Fig. 1). Treat-
ment with the anti-androgenic pharmaceutical alone caused a two
fold increase in the median vitellogenin concentration in compar-
ison to the solvent control, but this difference was not statistically
signiﬁcant at the 95% level. As expected, the steroid oestrogenmix-
ture signiﬁcantly induced vitellogenin. The combined mixture of
oestrogens and anti-androgens also signiﬁcantly induced vitello-
genin compared with the solvent control and again, although the
median was two-fold higher than the oestrogens alone, it was still
not statistically signiﬁcant. GSI signiﬁcantly varied between treat-
ment groups but there were no statistically signiﬁcant differences
between the treatment groups and the solvent control (Figure S5).
In comparison, HSI did not signiﬁcantly vary. For the secondary
sexual characteristics, only tubercle number and prominence were
signiﬁcantly reduced by the EE2 positive control, whereas the fat-
pad was unaffected. Apart from this there was no statistically
signiﬁcant impactof theoestrogen, anti-androgenandcombination
treatment on these endpoints (Figure S6).
Fig. 1. Log. vitellogenin concentrations in the bloodplasmaof fatheadminnow from
each treatment group. Vitellogenin was not quantiﬁed in some cases when values
were outside of the working range of the assay (N number of samples is indicated
out of 16 ﬁsh). Boxes represent themedianwith 25th and 75th percentiles and error
bars extending to the 95th percentile with outliers shown as dots. The labels A and
B denote a statistically signiﬁcant difference between groups at p≤0.05.
3.4. Experiment two: intersex induction and severity
Due to the long term nature of this study, some mortality was
unavoidable. This occurred in all treatment groups during the
experiment. On average, survival was over 80%. However, lower
survivalwas observed in onewater control tank (56%) and a solvent
control tank (72%). Survival was also lower in the two positive con-
trol tanks (60% and 68%),whichwere sampled early after 91 days as
a result. Theexact cause formortalitywasunknown, although in the
control tank temperature ﬂuctuations could be implicated. Indeed,
this tank experienced a greater temperature range (5.7 ◦C) than the
other tanks in this experiment. In the case of the positive con-
trols, previous studies have observed mortality in ﬁsh associated
with very high vitellogenin induction, which would be expected
Fig. 2. The proportions of intersex, male, female and unknown Japanese medaka within the treated populations based on gonad histology.
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Fig. 3. Images show a normal male gonad from the solvent control (A), sporadic oocytes in the testes (shown with arrows) typical of the low oestrogen and low mixture
treatment (B), increased abundance and clustering of oocytes in the testes typical of the high oestrogen and high mixture (C) and the extensive ﬁbrosis which occurred in
the testes of some high oestrogen and high mixture treated ﬁsh (D). The graph below shows statistical comparisons of the intersex severity between treatment groups. The
boxes represent the odds ratio value and extend to the 95% conﬁdence limits where a signiﬁcant difference is judged when the boxes exceed the value of 1 (indicated by *).
in the sex reversed males observed in this treatment (Herman and
Kincaid, 1988).
At the time of sampling, whilst all Japanese medaka in the
positive control population appeared phenotypically female char-
acteristics, the water and solvent controls appeared exclusively
male and a male majority was observed in all other treatments
based on their external appearance. This unexpected result was
conﬁrmed with gonad histology.
Intersex was based only on the presence of oocytes in testicular
tissue since ovarian cavities could not be properly quantiﬁed in
the longitudinal sections. Treatment of Japanese medaka with the
low and high steroid oestrogen concentrations induced intersex
in 22% and 70% (Fig. 2) of the respective treatment populations.
However, only the high oestrogen treatment induced what was
considered a signiﬁcant induction of intersex in comparison to
the solvent control, where intersex was identiﬁed in 6% of the
treatment population. A small proportion of ﬁsh in the low anti-
androgen treatment were also found to be intersex (6%), which did
not signiﬁcantly differ from the solvent control and no intersex ﬁsh
were found in the high anti-androgen treatment. Interestingly, in
both the low and high mixture treatments, the number of inter-
sex individuals was 9% and 10% higher, respectively, than their
corresponding oestrogen treatments alone. However, whilst inter-
sex incidence in these treatments was signiﬁcantly higher than
the solvent control, there was no signiﬁcant difference in inter-
sex induction between themixture treatments and their respective
oestrogen treatments.
Fig. 3 summarises the outcomes from the data analysis when
considering the severity of intersex. Intersex ﬁsh in the low anti-
androgen treatment was found to be at a low severity (index 1),
which did not signiﬁcantly differ from that occurring in the sol-
vent control. In comparison, severity in the low oestrogen and
the low mixture treatments was statistically similar with an index
around 1–2. Intersex index in these treatments was signiﬁcantly
higher than the solvent control. No intersex ﬁsh were identiﬁed
in the high anti-androgen treatment and severity of intersex in
the high oestrogen and high mixture treatments was signiﬁcantly
higher than in the lower treatments. Histological similarities were
observed in these two treatment groups with ﬁsh identiﬁed across
all bands of severity,with a tendency towardshigher severity (4–6).
In addition, ﬁsh in these treatments had increased levels of lobular
disorganisation in both intersex and non-intersex males. Fibrotic
tissue was also identiﬁed and, in some cases, it was severe enough
to make up a majority of the gonad tissue. Furthermore, intersex
ﬁshwithin both treatment groups showed reductions in spermato-
zoa in the sperm ducts in comparison to solvent control ﬁsh. In
someﬁsh, particularly thosewith extensive ﬁbrosis, the ductswere
empty (Figure S7). As a result, intersex ﬁsh with testes made up
primarily of ﬁbrotic tissue were classiﬁed as index 6 in statistical
analysis. The few femaleﬁshwhichwere identiﬁed in the treatment
groups were conﬁrmed as histologically female.
4. Discussion
This study aimed to determine the biological signiﬁcance of the
presence of anti-androgenic pharmaceuticals in the aquatic envi-
ronment by assessing their impacts on sexual disruption in ﬁsh,
aloneand in combinationwith co-occurring steroidoestrogens. The
results indicated that environmentally relevant concentrations of
up to 157ng/L bicalutamide and 86ng/L cyproterone acetate were
not sufﬁcient to induce signiﬁcant effects in ﬁsh either alone or
in combination with the steroid oestrogens. However, this study
clearly demonstrated that environmentally relevant mixtures of
steroid oestrogens were capable of causing sexual disruption in
ﬁsh, in terms of both vitellogenin induction and intersex. However,
secondary sexual characteristics, GSI and HSI in fathead minnow
were unaffected, and previous studies suggest that higher concen-
trations are required to impact these endpoints (Miles-Richardson
et al., 1999; Filby et al., 2007; Salierno and Kane, 2009). Indeed,
in this study only 10ng/L EE2 in the positive control signiﬁ-
cantly reduced tubercle number andprominence, althougha longer
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exposure to this concentration may have been required to affect
gross indices (Filby et al., 2007).
The induction of intersex by a mixture of steroid oestrogens
invites the question of whether this was an effect of a single
chemical or a combination of all three steroid oestrogens. Addi-
tive effects of steroid oestrogens are well documented and have
been observed both in vitro and in vivo, on endpoints including
vitellogenin production, fecundity and secondary sexual character-
istics in combinationwith other xenoestrogens (Thorpe et al., 2001;
Rajapakse et al., 2002; Silva et al., 2002; Brian et al., 2005, 2007).
However, additive effects have not been demonstrated for intersex,
although they are plausible. It should be noted that the concen-
trations of E2 and EE2 in the low oestrogen treatment were below
their reported LOECs of 0.75ng/L EE2 (Zhao et al., 2014) and 10ng/L
E2 for intersex induction (Metcalfe et al., 2001). In comparison,
E1 was detected above its LOEC of 10ng/L (Metcalfe et al., 2001).
However, the 10ng/L E1 exposure of Japanese medaka during early
life only induced 5% intersex, whilst 100ng/L induced 7% intersex
in the same study. In comparison, a much greater intersex inci-
dence of 24% of male ﬁsh was observed in experiment two in this
study. However, without detailed concentration response curves
from single chemical exposures it is not possible tomathematically
prove additive effects for this endpoint in this study. Nonetheless,
it remains clear that environmentally relevant concentrations of
steroid oestrogens are major drivers of intersex induction.
In comparison, the environmentally relevant concentrations
of anti-androgenic pharmaceuticals had no signiﬁcant impact on
the measured endpoints alone, when dosed without the addi-
tion of steroid oestrogens. Previous studies have found that these
endpoints can be affected by anti-androgenic pharmaceuticals in
single chemical exposure scenarios. However, the concentrations
required to induce signiﬁcant effects were in the microgram per
litre range, 1000 times higher than the exposure concentrations
in this study. For example, bicalutamide reduced tubercle promi-
nence at 100g/L (Panter et al., 2012), whilst cyproterone acetate
at concentrations up to 200g/L failed to have any signiﬁcant
impact on this endpoint (Ankley et al., 2010). Vitellogenin induc-
tion by anti-androgens has also been documented. One study
induced around a six fold increase in male fathead minnow fol-
lowing exposed to 500g/L of the pure AR antagonist ﬂutamide
(Jensen et al., 2004). In the current study, vitellogenin appeared
slightly elevated above the solvent control in the anti-androgen
treatment and in the mixture treatment in comparison to oestro-
gens alone, but this was not statistically signiﬁcantly higher. There
are no other studies of bicalutamide available for comparison
with this endpoint. However, there is some evidence to suggest
that it may act at similar concentrations to ﬂutamide in rodent
studies and it is therefore plausible that concentrations in the
microgram per litre range may be required to produce signiﬁ-
cant changes in vitellogenin in male ﬁsh (Chandolia et al., 1991;
Maucher and Von Angerer, 1993). In contrast, cyproterone acetate
reduced vitellogenin in female fathead minnow at 200g/L, pos-
sibly due to a reduction in endogenous sex steroids caused by
its anti-gonadotrophic effects in addition to its AR antagonism
(Ankley et al., 2010). By acting through both mechanisms, cypro-
terone acetate caused more pronounced effects than ﬂutamide
in mammalian models and in human trials for prostate cancer
treatment at similar doses (Barradell and Faulds, 1994). Indeed, in
ﬁsh studies, ﬂutamide caused intersex in medaka above 200g/L
(Kang et al., 2006; León et al., 2007) in comparison to cyproterone
acetate at 1 and 10g/L (Kiparissis et al., 2003). At the concentra-
tions employed in this study, cyproterone acetate has also been
shown to reduce both the testicular synthesis and plasma concen-
trations of testosterone and 11-ketotestosterone in mummichog
(Sharpe et al., 2004). However, this was not measured in this
study.
An unexpected ﬁnding of experiment two was the heavily male
biased sex ratio in the controls and all chemical treatments apart
fromthepositive control. Sex ratio canbe alteredby chemical expo-
sure (Örn et al., 2006) and it is used as an endpoint within the
OECD’s ﬁsh sexual development test (Test 234) (OECD, 2011). It has
gained interest for regulatory purposes as an endpoint for identify-
ing endocrine disruptors, since it can be considered to demonstrate
bothanadverse effect andanendocrinemodeof action, particularly
when used in conjunction with other endpoints, such as vitelloge-
nin induction (Craneetal., 2010;MunnandGoumenou,2013;Dang,
2014). However, sexual differentiation in ﬁsh can also be driven by
environmental factors, including temperature, hypoxia and even
changes in social hierarchy, depending on the species (Devlin and
Nagahama, 2002). Inmedaka, thermalmanipulation during the lar-
val and embryo stage has been shown to induce masculinisation
of genotypic XX females with exposure to increased temperature
(Sato et al., 2005; Hattori et al., 2007; Kitano et al., 2012). This
is thought to occur through an increase in cortisol in response
to external temperature change, which was shown to cause sup-
pression of germ cell proliferation, follicle stimulating hormone
receptor expression and ovarian-type aromatase (cyp19a1), aswell
as inhibition of oogenesis (Hayashi et al., 2010; Kitano et al., 2012).
However, the masculinisation effect induced by high temperature
or cortisol treatment was shown to be prevented by co-exposure
with E2, (Kitano et al., 2012). This provides a good explanation
for male dominated sex ratios in this study, which could have
been caused by temperature changes during media renewal in the
embryonic phase, where MFS water was kept at room tempera-
ture and not under incubation. However, this could not be proven.
Since E2 can challenge the masculinisation response to tempera-
ture changes (Kitano et al., 2012), statistical analysis of intersex
induction and severity was rerun with female histopathology con-
sidered as an experimental response, with an intersex index of
seven. However, the results were still no different from the original
analysis.
Phenotypic males produced by temperature induced sex rever-
sal have been found to have histologically normal, male testes and
were capable of successfully reproducing (Hattori et al., 2007). Con-
trol ﬁsh in this study were also found to have histologically normal
testes. This suggests that they still provide a sufﬁcient platform for
the induction of intersex by exogenous chemicals. Indeed, future
experiments could evenuse temperature in amore controlled fash-
ion to increase the n number of phenotypically male or female
ﬁsh for assessment of sex reversal or intersex induction. Nonethe-
less, the male dominated sex ratios highlight the importance of
maintaining experimental conditions during chemical exposure
studies and recognising the possibility of non-chemical effects on
this endpoint. It also supports the role of medaka in the ﬁsh sexual
development test, since it has a well-deﬁned genotypic sex deter-
mining gene (DMY) (Matsuda, 2005), which could be used to assess
non-chemical sex reversal in controls.
Whilst we found no evidence that the anti-androgenic pharma-
ceuticals could enhance or diminish a response to oestrogen
exposure, there still remains a possibility that oestrogenic and anti-
androgenic contaminants could act on ﬁsh in combination in the
environment, as indicated by Jobling et al. (2009). Indeed, com-
pounds with similar mechanisms of action, such as AR antagonists
andsteroidogenesis inhibitors, havebeenshowntoact additivelyor
even synergistically in vivo on commonendpoints in rodentmodels
(Christiansen et al., 2009; Hotchkiss et al., 2010). In ﬁsh, ﬂutamide
has also been shown to increase the expression of oestrogen recep-
tors ˇ and  in fathead minnow (Filby et al., 2007) and oestrogen
receptor ˛ in Murray rainbowﬁsh (Bhatia et al., 2014), suggest-
ing that there may be some common modes of action between AR
antagonists and oestrogens. Crucially, preliminary data from one
study has reported an increase in the incidence of ovarian cavities
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in juvenile roach following exposure to a combination of anti-
androgens identiﬁed in STW efﬂuents (by Rostkowski et al., 2011)
and steroid oestrogens (Lange et al., 2012). It may be that the total
anti-androgenic activity present in the environment, represent-
ing a larger number of compounds, could cause sexual disruption
in ﬁsh in combination with oestrogens. However, so far attempts
to characterise anti-androgenic activity in environmental samples
has found that the identiﬁed anti-androgenic compounds cannot
explain the total activity detected (Urbatzka et al., 2007; Kinani
et al., 2010). It may be that a large number of compounds are
contributing, of which the anti-androgenic pharmaceuticals are
a factor. Indeed, preliminary results from the Tox21 programme
found that almost 10% of the 1,462 compounds tested were andro-
gen receptor antagonists in vitro, which supports the possibility
of a large number of contributors to environmental activity (Tice
et al., 2013). Consequently, further study is warranted to identify
signiﬁcant environmental anti-androgens and to determine their
environmental impacts, particularly with respect to the possibility
of a multi-causal aetiology to sexual disruption observed in wild
ﬁsh.
5. Conclusions
Hydrological modelling predicted that bicalutamide and cypro-
terone acetate are likely to be widespread contaminants in rivers
in England and Wales. In a majority of cases, their concentrations
are likely to occur below 10ng/L, but at many “hot spots” concen-
trations are likely to be higher, in some cases exceeding 100ng/L
for bicalutamide. However, exposures of ﬁsh to these high envi-
ronmental concentrations suggested that they are not likely to be
a threat to ﬁsh reproductive health. Indeed, it is likely that concen-
trations one magnitude higher than those predicted to occur in the
environment are required to induce signiﬁcant responses associ-
ated with feminisation of wild ﬁsh. However, given the evidence
for additive effects of anti-androgenic chemicals in whole orga-
nisms, these environmental contaminants should be considered as
part of the wider issue of anti-androgenic activity in the environ-
ment. Critically, this study demonstrates that a mixture of steroid
oestrogens, at concentrations present in the aquatic environment,
can induce intersex at a rate comparable with that observed in
UK and European rivers. Additional exposures to anti-androgenic
pharmaceuticals known to co-occur with these oestrogens did not
exacerbate the incidence or severity of intersex. Taken together,
these data support the role of steroid oestrogens as major contrib-
utors to intersex in wild ﬁsh.
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